Kineta Inc.
Kineta Inc.
Kineta Inc.
Close
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • SEC filings
    • corporate governance
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean
  • about
    • company
    • team
    • board
    • SAB
  • pipeline
    • overview
    • KVA12123 (VISTA)
    • CD27
  • partnerships
  • investors
    • overview
    • press releases
    • events & presentations
    • stock information
    • SEC filings
    • corporate governance
  • careers
  • contact
  • en_USEnglish
    • ko_KRKorean

[be_recent_posts_author_no_link title=”Latest News from Kineta” category_id=”4,3″ num_posts=”6″ post_offset=”0″ num_words_limit=”0″ show_date_author=”1″ show_more_link=”0″ more_link_text=”Read more” show_thumbs=”0″ remove_thumb_frame=”0″ thumb_frame_shadow=”0″ default_thumb=”0″ post_thumb_width=”100″ post_thumb_height=”80″]

Recent Kineta News

  • Kineta Completes Reverse Merger with Yumanity Therapeutics
  • Kineta to Present KVA12123 VISTA Blocking Immunotherapy Program at Antibody Engineering and Therapeutics Conference
  • Kineta to Present at JMP Securities Hematology and Oncology Summit
  • Kineta Announces FDA Acceptance of Investigational New Drug (IND) Application for KVA12123 for the Treatment of Advanced Solid Tumors
  • Kineta Announces Effectiveness of Registration Statement on Form S-4 in Connection with Proposed Reverse Merger with Yumanity Therapeutics (YMTX)
Post placeholder image
May 4, 2017 in Biotech Industry News

RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study, Colon Cancer News Today

Kineta Inc 1 Like Post Comments Off on RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study, Colon Cancer News Today
Read More

219 Terry Ave. N. Suite 300. Seattle, WA 98109

Sign Up for Email Alerts

219 Terry Ave. N. Suite 300. Seattle, WA 98109

  • about
  • pipeline
  • partnerships
  • investors
  • contact
Sign Up for Email Alerts

© 2023 Kineta Inc.        Privacy Policy       Terms of Use

English
English
Korean